MedDataX Logo

Sleep Disordered Breathing and Lung Transplantation

NCT ID: NCT01179087

Last Updated: 2013-08-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2014-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to investigate the prevalence, clinical predictors and consequences (effect on survival, chronic rejection) of sleep disordered breathing in lung transplant recipients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients with end-stage respiratory failure who are referred for lung transplantation and are older than 18 years old are enrolled.

We collect:

* Medical history
* Blood pressure
* Anthropometrics
* Pulmonary function
* Arterial blood gas
* Questionnaire (QOL, ESS)
* Sleep diary
* Polysomnography

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Disordered Breathing Lung Transplantation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

sleep disordered breathing lung transplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with end-stage respiratory failure who are referred for lung transplantation
* Informed consent from patient

Exclusion Criteria

* Patients who are declined for lung transplantation
* Patients \< 18 years old
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

KU Leuven

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Marc Decramer

Prof. Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bertien MA Buyse, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

KU Leuven

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Katholieke Universiteit Leuven

Leuven, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bertien MA Buyse, MD, PhD

Role: CONTACT

Phone: +32 16 34 68 00

Email: [email protected]

Dries Testelmans, MD, PhD

Role: CONTACT

Phone: +32 16 34 68 00

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Bertien Buyse, MD, PhD

Role: primary

Dries Testelmans, MD, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

B32220109109

Identifier Type: -

Identifier Source: org_study_id